
Next Oncodistinct Network Scientific meeting
When : Thursday 18 and Friday 19 June 2026
Where : Nouvel Hôpital Civil (NHC) in Strasbourg – France
For more details, please send an e-mail to oncodistinct@hubruxelles.be

When : Thursday 18 and Friday 19 June 2026
Where : Nouvel Hôpital Civil (NHC) in Strasbourg – France
For more details, please send an e-mail to oncodistinct@hubruxelles.be

Grant Application Template 🚀 Oncodistinct Annual Grant – €20,000 To support academic clinical research within our network : Funding Amount: €20,000 Application Deadline: May 25, 2026 To

We’re pleased to announce the publication of the AVERectal study, a significant clinical research article led by Dr. Ali Shamseddine and his team at the

Call for Applications Grant Application Template 🚀 Oncodistinct Biannual Grant – €20,000 To support academic clinical research within our network : Funding Amount: €20,000 Application Deadline: June 1,

When : Thursday 19 and Friday 20 June 2025
Where : The Bank of Cyprus Oncology Centre in Nicosia (Cyprus).
For more details, please send an e-mail to oncodistinct@hubruxelles.be

📢 Francesco Sclafani and Ali Shamseddine from the Oncodistinct Network, had the opportunity to present Oncodistinct trials (REGINA & AVERECTAL) at the last ESMO GI 2024 in Munich, Germany

Oncodistinct Network achieved important milestones for SHAPERS and COPERNIC studies

Jérémy Blanc presented survival data results from AURA trial: Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004) at ASCO 2024 in Chicago, USA

We are pleased to announce that the next Oncodistinct Meeting will take place on Thursday 17th & Friday 18th October 2024 at the Institut Paoli-Calmettes in Marseille, France. Please save the date !

First results from our BRAINSTORM 🧠Program was presented by our our executive Officer Nuria Kotecki at AACR24 and EBCC14.